tiprankstipranks
Advertisement
Advertisement
XtalPi Launches Up to US$100 Million On-Market Share Buyback
PremiumCompany AnnouncementsXtalPi Launches Up to US$100 Million On-Market Share Buyback
2M ago
XtalPi Wins U.S. Safety Nod for Oral Peptide, Advances Pan-TEAD Cancer Drug
Premium
Company Announcements
XtalPi Wins U.S. Safety Nod for Oral Peptide, Advances Pan-TEAD Cancer Drug
3M ago
XtalPi Advances AI-Driven DoveTree Drug Collaboration, Unlocking Major Milestone Potential
Premium
Company Announcements
XtalPi Advances AI-Driven DoveTree Drug Collaboration, Unlocking Major Milestone Potential
3M ago
XtalPi Sets 2026 AGM to Seek Shareholder Mandates on Buy-backs and New Issues
PremiumCompany AnnouncementsXtalPi Sets 2026 AGM to Seek Shareholder Mandates on Buy-backs and New Issues
4M ago
XtalPi Grants Over 22 Million Equity Awards to Employees to Boost Incentives
Premium
Company Announcements
XtalPi Grants Over 22 Million Equity Awards to Employees to Boost Incentives
4M ago
XtalPi Swings to Profit on Surging 2025 Revenue and Heavy R&D Spend
Premium
Company Announcements
XtalPi Swings to Profit on Surging 2025 Revenue and Heavy R&D Spend
5M ago
XtalPi Completes HK$2.87 Billion Zero-Coupon Convertible Bond Issue to Fund AI-Driven R&D Expansion
PremiumCompany AnnouncementsXtalPi Completes HK$2.87 Billion Zero-Coupon Convertible Bond Issue to Fund AI-Driven R&D Expansion
7M ago
Premium
Company Announcements
XtalPi to Raise HK$2.87 Billion via Zero-Coupon Convertible Bonds for Global Expansion
7M ago
Premium
Company Announcements
XtalPi Announces Strategic Senior Management Change
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100